Author(s):
Khusnul, Yedy Purwandi Sukmawan, Meri, Nuniek Ina Ratnaningtyas, Nuraeni Ekowati
Email(s):
khusnul@universitas-bth.ac.id
DOI:
10.52711/0974-360X.2025.00582 
Address:
Khusnul1*, Yedy Purwandi Sukmawan2, Meri1, Nuniek Ina Ratnaningtyas3, Nuraeni Ekowati3
1Department of Medical Laboratory Technology, University of Bakti Tunas Husada, Tasikmalaya City, 46196, West Java, Indonesia.
2Department of Pharmacology and Clinical Pharmacy, University of Bakti Tunas Husada, Tasikmalaya City, 46196, West Java, Indonesia.
3Faculty of Biology, General Soedirman University (UNSOED), Purwokerto, 53122, Indonesia.
*Corresponding Author
Published In:
Volume - 18,
Issue - 9,
Year - 2025
ABSTRACT:
Diabetes mellitus is a chronic metabolic disorder that lead to various complications. Despite the availability of various medications for its management, adherence to conventional treatments can be challenging due to sociocultural factors that favor traditional medicine. Coprinus comatus, a traditional medicine with scientifically proven antidiabetic properties, is cultivated in both Cianjur and Yogyakarta, Indonesia. Previous research on Coprinus comatus has primarily focused on samples from Cianjur. Moreover, there has been no prior research on bioinformatics analysis between Cianjur and Yogyakarta cultivation, LC-MS profiling, and antidiabetic activity of Coprinus comatus cultivated in Yogyakarta. This study aimed to conduct bioinformatics analysis, LC-MS profiling, and evaluate the antidiabetic activity of Coprinus comatus cultivated in Yogyakarta. Results showed that Coprinus comatus samples from Yogyakarta exhibited genetic similarities to those from Cianjur based on genetic identification/DNA sequencing. Furthermore, the phytochemical profile of Coprinus comatus from Yogyakarta aligned with the previous finding, showing the presence flavonoids, alkaloids, saponins, and terpenoids. Despite these similarities, the antidiabetic activities of Coprinus comatus from the two regions differed significantly. Coprinus comatus from Yogyakarta exhibited a higher glucose-lowering effect, reaching 33.54% at a lower dose (200 mg/kg body weight) compared to previous studies on Coprinus comatus from Cianjur, which reported a 26.69% reduction in blood sugar at a higher dose (750 mg/kg body weight). The top ten compounds identified in Coprinus comatus from Yogyakarta, including Phytosphingosine, 1,3-Dihydroxy-2-propanyl, Ionene, 4-(Stearoylamino)butanoic acid, 1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC, Quinupramine, L-Ergothioneine, Docosatetraenoylethanolamide, (1R)-1-Phenyl-2-aminopropan-1-ol, and 1,2-Dilinoleoyl-sn-glycerol, may contribute to the observed antidiabetic effects. These findings suggest that Coprinus comatus cultivated in Yogyakarta has the potential to be developed as a promising traditional medicine for the treatment of diabetes mellitus.
Cite this article:
Khusnul, Yedy Purwandi Sukmawan, Meri, Nuniek Ina Ratnaningtyas, Nuraeni Ekowati. Bioinformatic Analysis, LC-MS Profiling, and Antidiabetic activity of Coprinus comatus in Alloxan-Induced Diabetic Male Mice. Research Journal of Pharmacy and Technology. 2025;18(9):4055-1. doi: 10.52711/0974-360X.2025.00582
Cite(Electronic):
Khusnul, Yedy Purwandi Sukmawan, Meri, Nuniek Ina Ratnaningtyas, Nuraeni Ekowati. Bioinformatic Analysis, LC-MS Profiling, and Antidiabetic activity of Coprinus comatus in Alloxan-Induced Diabetic Male Mice. Research Journal of Pharmacy and Technology. 2025;18(9):4055-1. doi: 10.52711/0974-360X.2025.00582 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2025-18-9-2
REFERENCES:
1. Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019; 157: 107843. doi:10.1016/j.diabres.2019.107843
2. Richards SE, Wijeweera C, Wijeweera A. Lifestyle and socioeconomic determinants of diabetes: Evidence from country-level data. PLoS One. 2022; 17(7July): 1-20. doi:10.1371/journal.pone.0270476
3. Kassaw H, Hussein K, Gebre A, Seid AA, Ammie M. Determinants of Overweight Among Type Two Diabetes Mellitus Patients Attending Public Hospitals At Awusi Resu Zone of Afar Region: Unmatched Case–Control Study. Diabetes, Metab Syndr Obes. 2024; 17(February): 759-767. doi:10.2147/DMSO.S436957
4. Panari H, Vegunarani M. Study on Complications of Diabetes Mellitus among the Diabetic Patients. Asian J Nurs Educ Res. 2016; 6(2): 171. doi:10.5958/2349-2996.2016.00032.x
5. Geetha V, Sahu SK, Susila C. Assess Quality of Life (QOL) and Glycemic Level among Type 2 Diabetic Patients in Global Hospital and Research Centre and its Units, Sirohi, Rajasthan. Asian J Nurs Educ Res. 2017; 7(4): 577. doi:10.5958/2349-2996.2017.00112.4
6. Bhardwaj J, Choudhary R, Sharma P. A comparative study on quality of life among type 1 and type 2 diabetes mellitus clients at selected hospitals of district Mohali, Punjab. Asian J Nurs Educ Res. 2018; 8(1): 152. doi:10.5958/2349-2996.2018.00032.0
7. Sharma P, Malik S. Knowledge on Management of Diabetes Mellitus among Patients with type II Diabetes Mellitus in a Selected Community Health Centre of Dadra and Nagar Haveli Area. Asian J Nurs Educ Res. 2019; 9(1): 109. doi:10.5958/2349-2996.2019.00021.1
8. Parsa P, Ahmadinia-Tabesh R, Mohammadi Y. Assessment of the risk of Coronary Heart Disease in Diabetes Patients Type-II. Asian J Nurs Educ Res. 2019; 9(2): 267. doi:10.5958/2349-2996.2019.00057.0
9. Joshi R. A Descriptive Study of the Prevalence of Diabetes Mellitus among Peoples residing in Valam Village, Mehsana, Gujarat. Asian J Nurs Educ Res. 2020; 10(1): 23. doi:10.5958/2349-2996.2020.00005.1
10. Awang Jihadi MH, Yuda A, Sukorini AI, et al. Drug-related problems in hospitalized patients with type 2 diabetes mellitus: A systematic review. Explor Res Clin Soc Pharm. 2023; 12(May): 100348. doi:10.1016/j.rcsop.2023.100348
11. Kumar K, Greenfield S, Raza K, Gill P, Stack R. Understanding adherence-related beliefs about medicine amongst patients of South Asian origin with diabetes and cardiovascular disease patients: A qualitative synthesis. BMC Endocr Disord. 2016; 16(1): 1-11. doi:10.1186/s12902-016-0103-0
12. Husen F, Hernayanti H, Ekowati N, Sukmawati D, Ratnaningtyas NI. Antidiabetic effects and antioxidant properties of the saggy ink cap medicinal mushroom, coprinus comatus (Agaricomycetes), in streptozotocin-induced hyperglycemic rats. Int J Med Mushrooms. 2021; 23(10): 9-21. doi:10.1615/INTJMEDMUSHROOMS.2021040020
13. Ratnaningtyas NI, Husen F. Profil Mikokimia dan Aktivitas Antidiabetes Jamur Coprinus comatus pada Tikus Model Hiperglikemia dengan Induksi Streptozotocin. J Mikol Indones. 2022; 6(1): 37-47. doi:10.46638/jmi.v6i1.204.Abstrak
14. Ratnaningtyas NI, Husen F, Sukmawati D, Wibowo ES, Hikam AR, Aksoy A. Antidiabetic Effects and Enzymatic Antioxidant Activity of Chicken Drumstick Mushroom (Coprinus comatus) Extract in Diabetic Rats Model. J Pure Appl Microbiol. 2022; 16(4): 2764-2774. doi:10.22207/JPAM.16.4.48
15. Ratnaningtyas NI, Hernayanti H, Ekowati N, Husen F. Ethanol extract of the mushroom Coprinus comatus exhibits antidiabetic and antioxidant activities in streptozotocin-induced diabetic rats. Pharm Biol. 2022; 60(1): 1126-1136. doi:10.1080/13880209.2022.2074054
16. Goetz P. Herbal medicine for diabetes . Phytothérapie du diabète. 2007; 5(4): 212-217. http://www.scopus.com/inward/record.url?eid=2-s2.0-36048952392&partnerID=40&md5=ecc605ec71fdab563c5abe5641b0fb95.
17. Yaqub Khan M, Aziz I, Bihari B, Kumar H, Roy M, Kumar Verma V. A Review-Phytomedicines Used in Treatment of Diabetes. Int J Pharmacogn. 2014; 1(6): 343-365. http://dx.doi.org/10.13040/IJPSR.0975-8232.IJP.1.
18. Farnsworth NR. Biological and phytochemical screening of plants. J Pharm Sci. 1966; 55(3): 225-276. doi:10.1002/jps.2600550302
19. Jose K D, Sebastian F, Franklin F, Davis D, Padanilath IB, Johnson J. A study to assess the Knowledge regarding glycemic control and self- management among diabetic patients in Amala Institute of Medical Sciences, Thrissur. Asian J Nurs Educ Res. 2021; 11(04): 571-576. doi:10.52711/2349-2996.2021.00133
20. Babu G, Bhaumik A, Krishnamachary K, Kalyani P. Synthetic Novel Flavanoid derivatives act as potential Antidiabetic agent against Streptozocin induced in diabetic Rats. Asian J Res Chem. 2018; 11(5): 799. doi:10.5958/0974-4150.2018.00141.4
21. Snel M, Sleddering MA, Pijl H, et al. The effect of dietary phytosphingosine on cholesterol levels and insulin sensitivity in subjects with the metabolic syndrome. Eur J Clin Nutr. 2010; 64(4): 419-423. doi:10.1038/ejcn.2009.154
22. Vieira R, Souto SB, Sánchez-López E, et al. Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome—review of classical and new compounds: Part-i. Pharmaceuticals. 2019; 12(4). doi:10.3390/ph12040152
23. Park J, Jung TW, Chung YH, Park ES, Jeong JH. 1,2-Dilinoleoyl-sn-glycero-3-phosphocholine increases insulin sensitivity in palmitate-treated myotubes and induces lipolysis in adipocytes. Biochem Biophys Res Commun. 2020; 533(1): 162-167. doi:10.1016/j.bbrc.2020.09.019